Quantcast
Viewing all articles
Browse latest Browse all 23

Public Health in the News: January 2025

Global/National The first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency has been approved, which can help with treatment and relapse prevention of Plasmodium vivax infection.  The 2025 Health Emergency Appeal was launched, asking for $1.25 billion to address ongoing health emergencies.  WHO’s 60-day plan focuses on expanding healthcare, increasing staff, and improving referrals and evacuations in Gaza. WHO regrets the U.S. decision to withdraw, emphasizing its crucial role in global health, and hopes for reconsideration and continued collaboration.  Guinea has eliminated the gambiense form of human African trypanosomiasis as a public health problem.  Niger is the first country in Africa to have met the criteria for onchocerciasis elimination.  FDA The FDA approved Journavx (suzetrigine) for moderate to severe acute pain in adults, a first-in-class non-opioid analgesic.  The FDA authorized the marketing of 20 ZYN nicotine pouch products, the first time the agency has authorized products commonly referred to as nicotine pouches.  Illinois – Illinois Department of Public Health (IDPH) / USA  IDPH has approved four conditions for medical cannabis treatment: (1) endometriosis, (2) ovarian cysts, (3) uterine fibroids, and (4) female orgasmic disorder.  Following Donald Trump’s executive order threatening to cut federal funding for hospitals that offer gender-affirming care to [...]

Viewing all articles
Browse latest Browse all 23

Trending Articles